Quetzal Therapeutics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia (NCT07504458) | Quetzal Therapeutics | 2026-06-08 |
Track Quetzal Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.